Mutagenesis of residues adjacent to transmembrane prolines alters D1 dopamine receptor binding and signal transduction

W Cho, LP Taylor and H Akil

Mental Health Research Institute, University of Michigan, Ann Arbor 48109-0720, USA. bcho@umich.edu

Proline is highly conserved in the presumed transmembrane alpha-helices of seven-transmembrane helix-containing, G protein coupled receptors. Unique properties of this imino acid have led to speculations of structural and perhaps dynamic importance for seven-transmembrane helix- containing receptor function. To avoid potentially deleterious consequences of proline-directed mutagenesis, substitutions were made in the X residue of X-Pro peptide bonds (where X is the residue on the amino-terminal side of proline), which may influence static geometries and potential agonist-induced conformational changes at the X-Pro peptide bond. In the fifth helix, Ile205 was substituted with either an alanine (I205A) or a tyrosine (I205Y). Similarly, in the sixth helix, Leu286 was substituted with either an alanine (L286A) or a tyrosine (L286Y). Mutant I205A demonstrated subtle changes in D1 pharmacology and signal transduction. The I205Y and L286Y mutations produced comparatively drastic impairments in both binding and signal transduction. Remarkably, the L286A mutation resulted in constitutive activity characterized by elevated basal signal transduction and increased agonist potencies. In addition, (R)-(+)-SCH23390, a classical antagonist at the wild-type D1 receptor, behaved as a partial agonist at L286A. This is the first report of a constitutively active receptor resulting from this point mutation and the first report of a constitutively active mutant dopamine receptor. These results are discussed in terms of binding pocket geometry and potential mechanisms of signal transduction.

Volume 50, Issue 5, pp. 1338-1345, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M Hellstrand, E A Danielsen, V M Steen, A Ekman, E Eriksson, and C L Nilsson The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells J. Med. Genet., November 1, 2004; 41(11): 867 - 871. [Full Text] [PDF]

				K. Tumova, R. M. Iwasiow, and M. Tiberi Insight into the Mechanism of Dopamine D1-like Receptor Activation. EVIDENCE FOR A MOLECULAR INTERPLAY BETWEEN THE THIRD EXTRACELLULAR LOOP AND THE CYTOPLASMIC TAIL J. Biol. Chem., February 28, 2003; 278(10): 8146 - 8153. [Abstract] [Full Text] [PDF]

				T. R. Ott, B. E. Troskie, R. W. Roeske, N. Illing, C. A. Flanagan, and R. P. Millar Two Mutations in Extracellular Loop 2 of the Human GnRH Receptor Convert an Antagonist to an Agonist Mol. Endocrinol., May 1, 2002; 16(5): 1079 - 1088. [Abstract] [Full Text] [PDF]

				D. J. Ford, A. Essex, T. A. Spalding, E. S. Burstein, and J. Ellis Homologous Mutations Near the Junction of the Sixth Transmembrane Domain and the Third Extracellular Loop Lead to Constitutive Activity and Enhanced Agonist Affinity at all Muscarinic Receptor Subtypes J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 810 - 817. [Abstract] [Full Text] [PDF]

				J. Marie, C. Koch, D. Pruneau, J.-L. Paquet, T. Groblewski, R. Larguier, C. Lombard, B. Deslauriers, B. Maigret, and J.-C. Bonnafous Constitutive Activation of the Human Bradykinin B2 Receptor Induced by Mutations in Transmembrane Helices III and VI Mol. Pharmacol., January 1, 1999; 55(1): 92 - 101. [Abstract] [Full Text]

				L. B. Kozell and K. A. Neve Constitutive Activity of a Chimeric D2/D1 Dopamine Receptor Mol. Pharmacol., December 1, 1997; 52(6): 1137 - 1149. [Abstract] [Full Text]

				M. Han, J. Lou, K. Nakanishi, T. P. Sakmar, and S. O. Smith Partial Agonist Activity of 11-cis-Retinal in Rhodopsin Mutants J. Biol. Chem., September 12, 1997; 272(37): 23081 - 23085. [Abstract] [Full Text] [PDF]

				L. L. Demchyshyn, F. McConkey, and H. B. Niznik Dopamine D5 Receptor Agonist High Affinity and Constitutive Activity Profile Conferred by Carboxyl-terminal Tail Sequence J. Biol. Chem., July 28, 2000; 275(31): 23446 - 23455. [Abstract] [Full Text] [PDF]